Dec 2023 | ||
---|---|---|
Total Revenue | ||
Cost of Revenue | ||
Gross Profit | ||
Gross Profit Margin (%) | ||
R&D Expense | ||
SG&A Expense | ||
Total Operating Expenses | ||
Operating Income or Loss | ||
Operating Margin (%) | ||
Interest Expense | ||
Total Other Income/Expenses | ||
Income Before Tax | ||
Income Tax Expense | ||
Income from Continuing Ops. | ||
Net Income | ||
Net Profit Margin (%) | ||
Net Income Available to Common Shareholders | ||
Basic EPS | ||
Diluted EPS | ||
Basic Average Shares | ||
Diluted Average Shares |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | ||
---|---|---|---|---|---|---|
Total Revenue | ||||||
Cost of Revenue | ||||||
Gross Profit | ||||||
Gross Profit Margin (%) | ||||||
R&D Expense | ||||||
SG&A Expense | ||||||
Total Operating Expenses | ||||||
Operating Income or Loss | ||||||
Operating Margin (%) | ||||||
Interest Expense | ||||||
Total Other Income/Expenses | ||||||
Income Before Tax | ||||||
Income Tax Expense | ||||||
Income from Continuing Ops. | ||||||
Net Income | ||||||
Net Profit Margin (%) | ||||||
Net Income Available to Common Shareholders | ||||||
Basic EPS | ||||||
Diluted EPS | ||||||
Basic Average Shares | ||||||
Diluted Average Shares |
Dec 2023 | ||
---|---|---|
Current Assets | ||
Cash & Cash Equivalents | ||
Marketable Securities | ||
Receivables | ||
Inventories | ||
Other Current Assets | ||
Total Current Assets | ||
Non-Current Assets | ||
Marketable Securities | ||
PPE Net | ||
Intangibles inc. Goodwill | ||
Other Non-Current Assets | ||
Total Non-Current Assets | ||
Total Assets | ||
Current Liabilities | ||
Accounts Payable | ||
Deferred Revenues | ||
Debt, Current | ||
Accrued Liabilities | ||
Other Current Liabilities | ||
Total Current Liabilities | ||
Non-Current Liabilities | ||
Deferred Revenues | ||
Debt, Non-Current | ||
Other Non-Current Liabilities | ||
Total Non-Current Liabilities | ||
Total Liabilities | ||
Shareholders' Equity | ||
Common Stock | ||
Additional Paid-In Capital | ||
Retained Earnings | ||
Other Shareholders' Equity | ||
Total Shareholders' Equity | ||
Total Liabilities & Shareholders' Equity |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | ||
---|---|---|---|---|---|---|
Current Assets | ||||||
Cash & Cash Equivalents | ||||||
Marketable Securities | ||||||
Receivables | ||||||
Inventories | ||||||
Other Current Assets | ||||||
Total Current Assets | ||||||
Non-Current Assets | ||||||
Marketable Securities | ||||||
PPE Net | ||||||
Intangibles inc. Goodwill | ||||||
Other Non-Current Assets | ||||||
Total Non-Current Assets | ||||||
Total Assets | ||||||
Current Liabilities | ||||||
Accounts Payable | ||||||
Deferred Revenues | ||||||
Debt, Current | ||||||
Accrued Liabilities | ||||||
Other Current Liabilities | ||||||
Total Current Liabilities | ||||||
Non-Current Liabilities | ||||||
Deferred Revenues | ||||||
Debt, Non-Current | ||||||
Other Non-Current Liabilities | ||||||
Total Non-Current Liabilities | ||||||
Total Liabilities | ||||||
Shareholders' Equity | ||||||
Common Stock | ||||||
Additional Paid-In Capital | ||||||
Retained Earnings | ||||||
Other Shareholders' Equity | ||||||
Total Shareholders' Equity | ||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | ||
---|---|---|
Cash Flows from Operating Activities | ||
Net Income | ||
Depreciation & Amortization | ||
Deferred Income Taxes | ||
Stock Based Compensation | ||
Accounts Receivable | ||
Inventory | ||
Accounts Payable | ||
Deferred Revenue | ||
Other Non-Cash | ||
Operating Cash Flow | ||
Cash Flows from Investing Activities | ||
PPE Investments | ||
Net Acquisitions | ||
Purchase of Investments | ||
Sale of Investments | ||
Other Investing Activity | ||
Investing Cash Flow | ||
Cash Flows from Financing Activities | ||
Debt Issued | ||
Proceeds from Debt Repayment | ||
Debt Repayment | ||
Proceeds from Sale of Equity | ||
Equity Repurchased | ||
Dividend Paid | ||
Other Financing Activity | ||
Financing Cash Flow | ||
Cash Position | ||
Beginning Cash Position | ||
End Cash Position | ||
Change in Cash | ||
Free Cash Flow | ||
Operating Cash Flow | ||
Capital Expenditure | ||
Free Cash Flow |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | ||
---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||
Net Income | ||||||
Depreciation & Amortization | ||||||
Deferred Income Taxes | ||||||
Stock Based Compensation | ||||||
Accounts Receivable | ||||||
Inventory | ||||||
Accounts Payable | ||||||
Deferred Revenue | ||||||
Other Non-Cash | ||||||
Operating Cash Flow | ||||||
Cash Flows from Investing Activities | ||||||
PPE Investments | ||||||
Net Acquisitions | ||||||
Purchase of Investments | ||||||
Sale of Investments | ||||||
Other Investing Activity | ||||||
Investing Cash Flow | ||||||
Cash Flows from Financing Activities | ||||||
Debt Issued | ||||||
Proceeds from Debt Repayment | ||||||
Debt Repayment | ||||||
Proceeds from Sale of Equity | ||||||
Equity Repurchased | ||||||
Dividend Paid | ||||||
Other Financing Activity | ||||||
Financing Cash Flow | ||||||
Cash Position | ||||||
Beginning Cash Position | ||||||
End Cash Position | ||||||
Change in Cash | ||||||
Free Cash Flow | ||||||
Operating Cash Flow | ||||||
Capital Expenditure | ||||||
Free Cash Flow |